Molecular and biological features of two new human squamous and adenocarcinoma of the lung cell lines

Cancer Genetics and Cytogenetics

Volumn 107, Issue 1, 1998, Pages 11-20

  Gasperi Campani, Anna ^c   Roncuzzi, Laura ^c   Ricotti, Luca ^a   Lenzi, Laura ^c   Gruppioni, Rita ^c   Sensi, Alberto ^c   Zini, Nicoletta ^b   Zoli, Wainer ^a   Amadori, Dino ^a  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b CNR   (Italy)

^c Department of Experimental Pathology ^*

Author keywords

[No Author keywords available]

Indexed keywords

NEURON SPECIFIC ENOLASE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CHROMOSOME 1Q; CHROMOSOME 2; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CYTOFLUOROMETRY; FEMALE; HUMAN; HUMAN CELL; KARYOTYPE; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MALE; NUMERICAL CHROMOSOME ABERRATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; STRUCTURAL CHROMOSOME ABERRATION;

ADENOCARCINOMA; AGED; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC MARKERS; HUMANS; KARYOTYPING; KERATINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032213621     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00076-4     Document Type: Article

References (29)

1. 1. Boring CC, Squires TS, Tong T, Montgomery S (1994): Cancer statistics. Ca Cancer J Clin 44:7-26.
2. 2. Makela TP, Mattson K, Alitalo K (1991): Tumor markers and oncogenes in lung cancer. Eur J Cancer 27:1323-1327.
3. 3. World Health Organization (1982): International Histological Classification of Tumors, 2nd ed. WHO, Geneva.
4. 4. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, Kondo H, Shimosato Y (1995): Small adenocarcinoma of the lung. Cancer 75:2844-2852.
5. 5. Devessa SS, Shaw GL, Blot WJ (1991): Changing patterns of lung cancer incidence by histological type. Cancer Epidemiol Biomarkers Preven 1:29-34.
6. 6. Gazadar AF (1994): The molecular and cellular basis of human lung cancer. Anticancer Res 13:261-268.
7. 7. Campling BG, Haworth AC, Baker HM, Greer DL, Holden JJA, Bradley EC, Pym J, Dexter DF (1992): Establishment and characterization of a panel of human lung cancer cell lines. Cancer 69:2064-2074.
8. 8. Negrini M, Castagnoli A, Pavan JW, Sabbioni S, Araujo D, Corallini A, Gualandi F, Rimessi P, Bonfatti A, Giunta C, Sensi A, Stanbridge EJ, Barbanti-Brodano G (1992): Suppression of tumorigenicity and anchorage-independent growth of BK virus-transformed mouse cells by human chromosome 11. Cancer Res 52:1297-1303.
9. 9. Dutrillaux B, Lejeune J (1975): New techniques in the study of human chromosomes: methods and applications. Adv Hum Genet 5:119-156.
10. 10. Seabright M (1972): The use of proteolytic enzymes for the mapping of structural rearrangement in the chromosomes of man. Chromosoma 36:204-210.
11. 11. Zoli W, Roncuzzi L, Flamigni A, Gruppioni R, Sensi A, Zini N, Amadori D, Gasperi-Campani A (1996): A new cell line from human infiltrating ductal carcinoma of the breast: establishment and characterization. J Cancer Res Clin Oncol 122:237-242.
12. 12. Tanigawa N, Kern DH, Hikasa Y, Morton DL (1982): Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. Cancer Res 42:2159-2164.
13. 13. Ausubel FM, Brent R, Kingston RE, Moore DD, Smith JA, Seidman JG, Struhl K (1989): Preparation and analysis of DNA. Vol I. In: Current Protocols in Molecular Biology. John Wiley & Sons, New York, pp. 2.2.1-2.2.3.
14. 14. Southern EM (1975): Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503-517.
15. 15. Dalla Favera R, Martinotti S, Gallo RC, Erikson J, Croce CM (1983):Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 219:963-967.
16. 16. King CR, Kraus MH, Aaronson SA (1985): Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229:974-976.
17. 17. Casey G, Smith R, McGillivray D, Peters G, Dickson C (1986): Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene. Mol Cell Biol 6:502-510.
18. 18. Watson R, Oskarsson M, Vande Woude GF (1982): Human DNA sequence homologous to the transforming gene (mos) of Moloney sarcoma virus. Proc Natl Acad Sci USA 79:4078-4082.
19. 19. Ranzani GN, Pellagata NS, Previderè C, Saragoni A, Vio A, Maltoni M, Amadori D (1990): Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients. Cancer Res 50:7811-7814.
20. 20. Taira M, Yoshida T, Miyagawa K, Sakamoto H, Terada M, Sugimura T (1987): cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc Natl Acad Sci USA 84:2980-2984.
21. 21. Pulciani S, Santos E, Lauver AV, Long LK, Barbacid M (1982): Transforming genes in human tumors. J Cell Biochem 20:51-61.
22. 22. Nau MM, Brooks BJ, Battey J, Sausville E, Gazdar AF, Kirsch IR, McBride OW, Bertness V, Hollis GF, Minna JD (1985): L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature 318:69-73.
23. 23. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J (1983): Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305:245-248.
24. 24. Spinazzi A, Soresi E, Boffi R, Nonis A, Noseda A, Cobelli S, Scanni A (1994): Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer. Cancer Detect Prev 18:209-220.
25. 25. Rabbitts PH (1994): Genetic changes in the development of lung cancer. Br Med Bull 50:688-697.
26. 26. Rodenhuis S, Slebos RJC (1992): Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 52:2665s-2669s.
27. 27. Mills NE, Fishman CL, Rom WN, Dubin N, Jacobson DR (1995): Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res 55:1444-1447.
28. 28. Kashii T, Mizushima Y, Monno S, Nakagawa K, Kobayashi M (1994): Gene analysis of K-, H-ras, p53 and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method. J Cancer Res Clin Oncol 120:143-148.
29. 29. Gasperi-Campani A, Roncuzzi L, Zoli W, Lenzi L, Gruppioni R, Sensi A, Zini N, Farabegoli F, Amadori D (1998): Chromosomal alterations, biological features and in vitro chemosensitivity of SCLC-R1, a new cell line from human metastatic small cell lung carcinoma. Eur J Cancer 36:726-730.